Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
poractant alfa (curosurf) (1 trial)
Bronchopulmonary Dysplasia (Phase 4)
Hyperplasia (Phase 4)
Infant, Premature, Diseases (Phase 4)
Respiratory Distress Syndrome (Phase 4)
Respiratory Distress Syndrome, Newborn (Phase 4)
Trials (1 total)
Trial APIs (1 total)